spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Drug Discovery 2018

SMi Drug Discovery 2018

21-22 March 2018
Copthorne Tara Hotel, Scarsdale Place, Kensington, London

SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March.

The pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently, the event will focus on key developments in this very industry.

SMi’s 2nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery, CRISPR and PROTAC’s, as well as discussing advancements in medicinal chemistry, translational medicine and 3D structure based-discovery.

With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:

 

Chairman - Darren Green, Director of Molecular Design,GSK

Chairman - Guido Hanauer, Chief Executive Officer, GHPC GmbH

Steve Rees, Vice President, Discovery Biology, AstraZeneca

Stevan W Djuric, PhD, Vice President, Discovery Chemistry and Technology, AbbVie

John Harling, Director of Chemistry for the Protein Degradation DPU, GSK

Ursula Egner, Director, Head of Structural Biology, Bayer AG

Ralph Minter, Director, Fellow, Antibody Discovery and Protein Engineering, MedImmune
 

Early bird discounts!

Register by the 30th November to save £400

15th December to save £200

31st January to save £100

Register online at: https://www.drug-discovery.co.uk/samedan

For more information please contact: +44 (0) 207 827 6020 or email: nboumediene@smi-online.co.uk

phone +44 (0) 207 827 6020
email events@smi-online.co.uk
web bit.ly/2m1E9dk
 
Print this page
Send to a friend
   
spacer
Industry Events

9th Global Drug Delivery & Formulation Summit

12-14 March 2018, Maritim proArte Hotel Berlin

The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development.
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan

Banner of ChinaBio_Events_102 on Samedan
White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>


News and Press Releases

BioGenes Establishes Scientific Advisory Board

Berlin, Germany, December 12, 2017 / B3C newswire / -- BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, today announces the establishment of a Scientific Advisory Board which includes the following four renowned experts:
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement